Duality Advisers, LP Bristol Myers Squibb CO Transaction History

Duality Advisers, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$48.48 - $57.85 $2.98 Million - $3.56 Million	61,525 Added 1700.53%	65,143 $3.34 Million
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $209,446 - $234,193	3,618 New	3,618 $209,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $1.96 Million - $2.32 Million	28,553 New	28,553 $2.05 Million
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $4.31 Million - $4.75 Million	59,411 New	59,411 $4.58 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $6.45 Million - $7.73 Million	-104,878 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $1.08 Million - $1.25 Million	20,062 Added 23.65%	104,878 $6.54 Million
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $3.57 Million - $4.18 Million	60,313 Added 246.15%	84,816 $5.02 Million
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $1.52 Million - $1.65 Million	24,503 New	24,503 $1.64 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $423,568 - $476,390	-7,138 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $412,148 - $467,039	7,138 New	7,138 $443,000
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $18.4 Million - $24 Million	-373,760 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $9.86 Million - $11.7 Million	230,530 Added 160.95%	373,760 $19 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $6.39 Million - $7.07 Million	143,230 New	143,230 $6.5 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.